Skip to content

Samantha Salas

NPI 1346850773ActiveIndividual· Nurse Practitioner· Stanford, CA

Nurse Practitioner in Stanford, California, licensed in CA, with an NPI issued in July 2020. Part D covered 67 prescriptions written in 2024, 79% of them generic. Takeda Pharmaceuticals U.S.A., Inc. reported $18.13 in payments in 2025, mostly food and beverage.

Overview

NPI1346850773
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJul 31, 2020
Last updated in NPPESJun 26, 2023
Certified by providerJun 26, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Nurse Practitioner Primary363L00000X95025473CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nurse Practitioner (CA)

Part D prescriptions in 2024

Prescriptions (claims)67 · 97 30-day fills
Patients26
Total drug cost$10,170
Generic share79% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$18.13 · 1 payment from 1 company
  • 2024$31.01 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$18.131

What the 2025 payments were for

  • Food and Beverage$18.13 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nurse practitioners in Stanford

All 589 nurse practitioners in Stanford · All nurse practitioners in California